KYTX logo

Kyverna Therapeutics (KYTX) Selling, General & Administrative Expenses

Annual SGA

$12.48 M
+$4.48 M+55.90%

December 31, 2023


Summary


Performance

KYTX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXexpensesmetrics:

Quarterly SGA

$9.58 M
+$3.46 M+56.64%

September 30, 2024


Summary


Performance

KYTX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXexpensesmetrics:

TTM SGA

-$716.35 M
-$110.66 M-18.27%

September 30, 2024


Summary


Performance

KYTX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKYTXexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

KYTX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+55.9%+127.3%-5838.6%
3 y3 years+103.0%+127.3%-5838.6%
5 y5 years+103.0%+127.3%-5838.6%

KYTX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+103.0%at high+381.3%-846.6%at low
5 y5-yearat high+103.0%at high+381.3%-846.6%at low
alltimeall timeat high+103.0%at high+381.3%-846.6%at low

Kyverna Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$9.58 M(+56.6%)
$26.79 M(+35.0%)
Jun 2024
-
$6.11 M(-11.2%)
$19.85 M(+19.3%)
Mar 2024
-
$6.88 M(+63.3%)
$16.63 M(+33.2%)
Dec 2023
$12.48 M
$4.21 M(+59.7%)
$12.48 M(+21.7%)
Sep 2023
-
$2.64 M(-8.9%)
$10.26 M(+34.6%)
DateAnnualQuarterlyTTM
Jun 2023
-
$2.90 M(+6.0%)
$7.62 M(+61.3%)
Mar 2023
-
$2.73 M(+37.4%)
$4.72 M(+137.4%)
Dec 2022
$8.01 M(+30.2%)
-
-
Dec 2022
-
$1.99 M
$1.99 M
Dec 2021
$6.15 M
-
-

FAQ

  • What is Kyverna Therapeutics annual SGA?
  • What is the all time high annual SGA for Kyverna Therapeutics?
  • What is Kyverna Therapeutics annual SGA year-on-year change?
  • What is Kyverna Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Kyverna Therapeutics?
  • What is Kyverna Therapeutics quarterly SGA year-on-year change?
  • What is Kyverna Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Kyverna Therapeutics?
  • What is Kyverna Therapeutics TTM SGA year-on-year change?

What is Kyverna Therapeutics annual SGA?

The current annual SGA of KYTX is $12.48 M

What is the all time high annual SGA for Kyverna Therapeutics?

Kyverna Therapeutics all-time high annual SGA is $12.48 M

What is Kyverna Therapeutics annual SGA year-on-year change?

Over the past year, KYTX annual SGA has changed by +$4.48 M (+55.90%)

What is Kyverna Therapeutics quarterly SGA?

The current quarterly SGA of KYTX is $9.58 M

What is the all time high quarterly SGA for Kyverna Therapeutics?

Kyverna Therapeutics all-time high quarterly SGA is $9.58 M

What is Kyverna Therapeutics quarterly SGA year-on-year change?

Over the past year, KYTX quarterly SGA has changed by +$5.36 M (+127.27%)

What is Kyverna Therapeutics TTM SGA?

The current TTM SGA of KYTX is -$716.35 M

What is the all time high TTM SGA for Kyverna Therapeutics?

Kyverna Therapeutics all-time high TTM SGA is -$75.68 M

What is Kyverna Therapeutics TTM SGA year-on-year change?

Over the past year, KYTX TTM SGA has changed by -$728.83 M (-5838.60%)